Related Experiment Video
Updated: Nov 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy
Georgios Efthimiadis1, Thomas Zegkos2, Despoina Parcharidou2
11st Cardiology department, Laboratory of Cardiomyopathies and Inherited Cardiac Diseases, AHEPA University hospital, Thessaloniki 54636, Greece.
Insights
Hypertrophic cardiomyopathy (HCM), a common inherited heart disease, requires a structured diagnostic and management approach. This review outlines a simple algorithm for newly diagnosed HCM patients, focusing on risk stratification and tailored therapeutic strategies.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac condition, affecting approximately 0.2% of the population.
- It follows an autosomal dominant inheritance pattern, necessitating thorough family history evaluation.
- Differentiating HCM from other causes of left ventricular hypertrophy, like cardiac amyloidosis, is crucial for accurate diagnosis.
Purpose of the Study:
- To present a simplified management algorithm for patients newly diagnosed with HCM.
- To emphasize the importance of early etiological diagnosis and risk stratification.
- To describe therapeutic strategies based on disease presentation and progression.
Main Methods:
- Initial assessment includes clinical examination, detailed medical and family history, and electrocardiography (ECG).
- Cardiovascular imaging and ambulatory electrocardiography are key diagnostic tools.
- Etiological diagnosis to distinguish genetic HCM from phenocopies is essential.
- Cardiopulmonary exercise testing may be utilized for further assessment.
Main Results:
- The diagnostic process aids in differentiating HCM from other conditions causing left ventricular hypertrophy.
- Risk stratification for sudden cardiac death is a critical component of patient management.
- The algorithm facilitates tailored therapeutic strategies for obstructive, non-obstructive, and end-stage HCM.
Conclusions:
- A systematic approach is vital for managing patients with hypertrophic cardiomyopathy.
- Accurate diagnosis and risk stratification guide effective treatment decisions.
- This algorithm provides a framework for comprehensive HCM patient care.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease with an autosomal dominant pattern and a reported prevalence of about 0.2%. In this review, we present a simple algorithm for the management of first diagnosed HCM patients. Initially, the clinical examination, medical and detailed family history and the ECG are essential. The etiological diagnosis of left ventricular hypertrophy is important in order to differentiate HCM due to sarcomeric genes mutation from other phenocopies, such as cardiac amyloidosis. The next step consists of the cardiovascular imaging and ambulatory electrocardiography. Cardiopulmonary exercise testing may also be considered if available. All of the above provide evidence for the critical step of the risk stratification of patients for sudden cardiac death. The therapeutic strategy, with respect to obstructive and nonobstructive disease, arrhythmias and end-stage HCM is also described.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Atherosclerosis III: Management

